Cancer Research UK Cambridge Institute

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

This International Women’s Day, meet the women combining research and clinical expertise with business acumen and personal experience to help…

In 2019, we launched our flagship early detection initiative, the International Alliance for Cancer Early Detection (ACED), to address the…

We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…

From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer.

We hear from two Cancer Research UK scientists, Ashley Nicholls and Jessica Taylor, about their interesting career changes.

Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.